Law and Ethics of Non-Invasive Prenatal Testing

Thursday, November 06, 2014 12:00 PM
Lectures and Panels
2014-2015
Wasserstein Hall, Room 3018
1585 Massachusetts Ave., Cambridge, MA

The Petrie-Flom Center will host a discussion of the issues surrounding noninvasive prenatal testing (NIPT), a screening method for detecting certain…

Read More

Emerging Issues and New Frontiers for FDA Regulation

Monday, October 20, 2014 8:00 AM - 5:00 PM
Conferences
2014-2015
Washington, DC

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Food and Drug Law Institute are pleased to…

Read More

F.D.A. Acts on Lab Tests Developed In-House

New York Times, July 31, 2014
by Andrew Pollack

The Food and Drug Administration announced on Thursday that it would start regulating medical laboratory testing, saying that tests used to make important treatment decisions must be vetted and validated…

Read More

Genetically Engineering Almost Anything

"NovaNext," PBS, July 17, 2014
by Tim DeChant and Eleanor Nelsen

[...] A new technology just announced today has the potential to wipe out diseases, turn back evolutionary clocks, and reengineer entire ecosystems, for better or worse. Because of how deeply this…

Read More

Scientists create first-ever ‘biological pacemaker’ in pig hearts:

Al Jazeera America, July 16, 2014
by Marisa Taylor

Cardiologists have transplanted genes into the hearts of pigs with heart arrhythmias and genetically reprogrammed their defective heart cells into beating again, creating what they’re calling a “biological pacemaker,” according…

Read More

Call for Submissions: Journal of Law and the Biosciences

Call for Submissions: Journal of Law and the Biosciences

Deadline: Rolling admission.

Journal of Law and the Biosciences (JLB) is actively soliciting original manuscripts, responses, essays, and book reviews devoted to the examination of issues related to the intersection of law and biosciences, including bioethics, neuroethics, genetics,…

Read More

VIDEO NOW AVAILABLE: Using Big Data To Transform Care

HealthAffairs, July 9, 2014
by Featuring I. Glenn Cohen (Faculty Director)

The application of big data to transform health care delivery, health research, and health policy is underway, and its potential is limitless.  The July 2014 issue of Health Affairs, "Using Big…

Read More

Using Big Data To Transform Care:

Health Affairs, July 9, 2014, 9:00am - 12:30pm
by Featuring I. Glenn Cohen (Faculty Director)

The application of big data to transform health care delivery, health research, and health policy is underway, and its potential is limitless.  The July 2014 issue of Health Affairs, "Using…

Read More

Who’s your daddy? Study on genetic testing says parents don’t need to know:

Al Jazeera America, June 23, 2014
by Joseph Brownstein

As more research is done on the human genome and more people seek genetic testing, researchers, physicians, genetic counselors and ethicists are struggling with the issues of how to present…

Read More

Video Now Available: What is Life?

Radcliffe Institute, May 30, 2014
by Featuring I. Glenn Cohen (Faculty Director)

How has knowledge of the human genome transformed the biological sciences? How should we assess the promises, perils, and ethics of creating new organisms in the laboratory? Eric S. Lander (moderator),…

Read More

Post-Doctoral Fellowship in Biomedical Ethics Research

Post-Doctoral Fellowship in Biomedical Ethics Research
Mayo Clinic, Rochester, Minn.

Deadline: Open until filled.

Position Start Date: As negotiated with the successful applicant. Qualifications: Ph.D. or other terminal degree (J.D., M.D.) with experience in bioethics. Must have excellent written and oral communication skills. Experience with normative bioethics analyses, survey…

Read More

In a First, Test of DNA Finds Root of Illness

New York Times, June 4, 2014
by Carl Zimmer

Joshua Osborn, 14, lay in a coma at American Family Children’s Hospital in Madison, Wis. For weeks his brain had been swelling with fluid, and a battery of tests had…

Read More

What is Life?

Radcliffe Institute, May 30, 2014, 4:00-5:15pm
by Featuring I. Glenn Cohen (Faculty Director)

Registration is required in order to attend this event. Please register here. How has knowledge of the human genome transformed the biological sciences? How should we assess the promises, perils,…

Read More

2014 Annual Conference:
Behavioral Economics, Law, and Health Policy

Saturday, May 03, 2014
Conferences
2013-2014
Wasserstein Hall, Milstein East ABC
1585 Massachusetts Ave., Cambridge, MA

Couldn't join us in person at Harvard Law School? Join the conversation on Twitter using #BELHP2014! We also liveblogged the full event at Bill…

Read More

Michelle N. Meyer Named to Board of Directors of PersonalGenomes.org

Petrie-Flom, May 1, 2014

Academic Fellow alumna Michelle Meyer, J.D., Ph.D., currently Assistant Professor and Director of Bioethics Policy in the Union Graduate College-Icahn School of Medicine at Mt. Siniar Bioethics Program, has been named to…

Read More

Cloned embryos yield stem cells for diabetes

Chicago Tribune, April 28, 2014

And now there are three: in the wake of announcements from laboratories in Oregon and California that they had created human embryos by cloning cells of living people, a lab…

Read More

FDA approves genetic test as first U.S. alternative to Pap smear

Washington Post, April 24, 2014
by Matthew Perrone

Federal health regulators have cleared a genetic test from Roche as the first U.S.-approved alternative to the Pap smear, the decades-old mainstay of cervical cancer screening. The Food and Drug…

Read More

Vermont Will Require Labeling of Genetically Altered Foods

New York Times, April 23, 2014
by Stephanie Strom

Going further than any state so far, Vermont on Wednesday passed a lawrequiring the labeling of foods that contain genetically engineered ingredients. Though the move came in a tiny state far…

Read More

What (If Anything) Is Wrong with Human Enhancement? What (If Anything) Is Right with It?

Tulsa Law Review, vol. 49, 2014
by I. Glenn Cohen (Faculty Director)

Abstract:  Should human enhancement be prohibited? Subsidized? Mandated? Taxed?  This article is part of a symposium honoring one of my wonderful mentors: Einer Elhauge. It focuses on human enhancement. With…

Read More

Hot Topics at the Presidential Commission for the Study of Bioethical Issues:
Plus Q&A on Careers in Law and Bioethics!

Friday, April 11, 2014 12:00 PM
Lectures and Panels
2013-2014
Pound Hall 100
1563 Massachusetts Ave., Cambridge, MA

This event featured an update from the Presidential Commission for the Study of Bioethical Issues delivered by Michelle Groman (HLS '05), Associate Director at the…

Read More

Journal of Law and the Biosciences (JLB) Soliciting Commentaries

Journal of Law and the Biosciences (JLB) Soliciting Commentaries

Deadline: May 05, 2014

Journal of Law and the Biosciences is pleased to solicit Peer Commentaries for the following articles: The Regulation of Cognitive Enhancement Devices, by Hannah Maslen, Thomas Douglas, Roi Cohen Kadosh, Neil Levy,…

Read More

Make it Work!:

Harvard Law Review 128, 2014
by I. Glenn Cohen (Faculty Co-Director)

This short essay is part of a Harvard Law Review Symposium honoring Justice Breyer on his 20th Year on The Supreme Court. It examines Breyer's opinions and impact on the…

Read More

Health Law Workshop: Hank Greely

Monday, March 24, 2014 5:00 PM
Health Law Workshops
2013-2014
Hauser 105
1575 Massachusetts Ave., Cambridge, MA

Download excerpts from Hank Greely's new book, The End of Sex: The Future of Human Reproduction, here. Hank Greely is Director for the Center…

Read More

An Interview with I. Glenn Cohen on Law and Bioscience

OUP Blog, March 14, 2014

There are huge changes taking place in the world of biosciences, and whether it's new discoveries in stem cell research, new reproductive technologies, or genetics being used to make predictions…

Read More

Academic Fellow W. Nicholson Price II Appointed Asst. Professor at UNH School of Law

Petrie-Flom Center, March 13, 2014

Petrie-Flom Academic Fellow Nicholson Price has been appointed as an Assistant Professor at the University of New Hampshire School of Law, where he will research and teach on intellectual property, innovation policy, and…

Read More

Alzheimer’s Blood Test Raises Ethical Questions

NPR, March 9, 2014
by Jon Hamilton

An experimental blood test can identify people in their 70s who are likely to develop Alzheimer's disease within two or three years. The test is accurate more than 90 percent…

Read More

China Cracks Down on DNA Testing

Forbes, March 3, 2014
by Shu-Ching Jean Chen

Genetic testing has grown to be a business big enough in China to warrant the government’s intervention. Early in February, the government quietly put the brakes on the provision of…

Read More

A Powerful New Way to Edit DNA

New York Times, March 3, 2014
by Andrew Pollack

In the late 1980s, scientists at Osaka University in Japan noticed unusual repeated DNA sequences next to a gene they were studying in a common bacterium. They mentioned them in…

Read More

Rare Mutation Kills Off Gene Responsible for Diabetes

New York Times, March 2, 2014
by Gina Kolata

A new study based on genetic testing of 150,000 people has found a rare mutation that protects even fat people from getting Type 2 diabetes. The effect is so pronounced…

Read More

Frances Kamm’s Bioethical Prescriptions:
Book Talk and Panel Discussion

Thursday, February 27, 2014 2:00 to 3:30 PM
Lectures and Panels
2013-2014
Wasserstein Hall 1019
1585 Massachusetts Ave., Cambridge, MA

We hosted this book talk and panel discussion for Professor Frances Kamm's latest book, Bioethical Prescriptions: To Create, End, Choose, and…

Read More

The First Issue of Journal of Law and Biosciences Is Now Available!

Petrie-Flom Center, February 27, 2014

We are pleased to announce that the first issue of Journal of Law and the Biosciences (JLB) is now available online. The articles are: Knoppers, Bartha M., Edward S. Dove, &…

Read More

Blood Test Provides More Accurate Prenatal Testing For Down Syndrome

NPR, February 26, 2014
by Rob Stein

A new blood test offers pregnant women a safe and much more accurate way to screen for Down syndrome. A study that evaluated the test in 1,914 pregnancies found that…

Read More

Health Law Workshop: I. Glenn Cohen

Monday, February 17, 2014 5:00 PM
Health Law Workshops
2013-2014
Hauser 105
1575 Massachusetts Ave., Cambridge, MA

Professor Cohen's papers, "What (if anything) is Wrong with Human Enhancement? What (if anything) is Right With It?" and "This Is…

Read More

Della Wolf is B.C.‘s 1st child with 3 parents on birth certificate:

CBC News, February 10, 2014
by Catherine Rolfsen

A Vancouver baby has just become the first child in British Columbia with three parents listed on a birth certificate. Three-month-old Della Wolf Kangro Wiley Richards is the daughter of…

Read More

Ethics Questions Arise as Genetic Testing of Embryos Increases

New York Times, February 3, 2014
by Gina Kolata

[...]  Genetic testing of embryos has been around for more than a decade, but its use has soared in recent years as methods have improved and more disease-causing genes have…

Read More

Genetic Weapon Against Insects Raises Hope and Fear in Farming

New York Times, January 27, 2014
by Andrew Pollack

Scientists and biotechnology companies are developing what could become the next powerful weapon in the war on pests — one that harnesses a Nobel Prize-winning discovery to kill insects and…

Read More

Harvard Scientists Say Research Subjects Should See Data

Bloomberg Technology, January 23, 2014
by John Lauerman

People who give blood or other tissues for research should be able to track their use through the scientific process to see the data their activities or samples generate, Harvard…

Read More

Legal Aspects of Biobanking as Key Issues for Personalized Medicine & Translational Exploitation

by Timo Minssen (Petrie-Flom Visiting Scholar) and Jens Schovsbo

Abstract: This perspective-article provides an overview on selected legal aspects of biobanking. It discusses these issues with a focus on public biobanks in a university setting and the specific challenges posed…

Read More

I Had My DNA Picture Taken, With Varying Results

New York Times, December 30, 2013
by Kira Peikoff

[...] I turned to genetic testing, but I wondered if I could trust the nascent field to give me reliable results. In recent years, a handful of studies have found…

Read More

Insurers Question Health Benefits Of Some Genetic Tests

Kaiser Health News, December 10, 2013
by Michelle Andrews

The day when a simple blood test or saliva sample can identify your risk for medical conditions ranging from cancer to Alzheimer’s disease seems tantalizingly close. But while advances in…

Read More

Anne Wojcicki Speaks Out About the F.D.A. Crackdown on 23andMe

New York Times, December 4, 2013
by Claire Cain Miller

Anne Wojcicki, co-founder and chief executive of 23andMe, the genetic testing company backed by Google, spoke Tuesday night for the first time about the Food and Drug Administration’s crackdown on her company. The…

Read More

Now Available: Bioethical Prescriptions:

Oxford University Press, 2013
by Frances Kamm

Bioethical Prescriptions collects Frances M. Kamm's articles on bioethics, which have appeared over the last twenty-five years and which have made her among the most influential philosophers in this area. Kamm is…

Read More

Announcing the New Journal of Law and the Biosciences

Oxford University Press, Forthcoming 2014
by Petrie-Flom Center and HLS, Duke University, and Stanford University

The Petrie-Flom Center and Harvard Law School are delighted to announce our partnership with Duke University, Stanford University, and Oxford University Press to launch a new peer-reviewed, open access, online…

Read More

Disabled baby denied heart transplant

CNN, November 30, 2013
by Elizabeth Cohen

The mood in the room was somber as five doctors, a nurse, and a social worker pulled their chairs around the table and turned to address Autumn Chenkus and Charlie…

Read More

FDA warns Google-backed 23andMe to halt sales of genetic tests

Reuters, November 25, 2013
by Toni Clarke and Sharon Begley

The U.S. Food and Drug Administration has warned 23andMe, a company backed by Google Inc, to halt sales of its genetic tests because they have not received regulatory clearance. 23andMe, which was…

Read More

Genes without Patents

Harvard Gazette, November 14, 2013
by Alvin Powell, featuring I. Glenn Cohen

As Supreme Court Justice Elena Kagan questioned Myriad Genetics’ attorney about patenting genes, Chris Hansen rejoiced. The attorney said that yes, genes should be patentable. But it was only under…

Read More

Alzheimer’s risk before symptoms:

CNN, November 9, 2013
by Elizabeth Landau

[...] to set up human experiments aimed at prevention, researchers need to identify a whole new category of patient: Those in the "preclinical" stage of Alzheimer's. By performing brain scans…

Read More

Massive DNA volunteer hunt begins

BBC News, November 6, 2013
by James Gallagher

The UK Personal Genome Project could provide a massive free tool for scientists to further understanding of disease and human genetics. Participants will get an analysis of their DNA, but so will…

Read More